Evidence that most high-affinity ATP binding sites on aortic endothelial cells and membranes do not correspond to P-2 receptors

被引:16
作者
Motte, S
Swillens, S
Boeynaems, JM
机构
[1] SCH MED,INST INTERDISCIPLINARY RES,BRUSSELS,BELGIUM
[2] FREE UNIV BRUSSELS,HOP ERASME,DEPT CLIN CHEM,B-1070 BRUSSELS,BELGIUM
关键词
ATP; purinergic; nucleotide; purinoceptor; endothelial cell;
D O I
10.1016/0014-2999(96)00234-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has recently been demonstrated that two types of ATP receptors, the P-2Y and P-2U receptors, are coexpressed on bovine aortic endothelial cells. The aim of the present study was to characterize directly P-2Y and P-2U subtypes on intact bovine aortic endothelial cells and on membranes prepared from these cells using adenosine 5'-0-(3-thio[S-35]triphosphate) ([S-35]ATP gamma S), [alpha-P-32]ATP and [alpha-P-32]UTP as radioligands. [S-35]ATP gamma S binding to bovine aortic endothelial cell membranes was saturable and apparently involved a single class of high-affinity binding sites (K-d: 14 +/- 11 nM; B-max: 1.6 +/- 0.7 pmol/mg protein; mean +/- S.D.). A similar class of high-affinity binding sites was identified with [alpha-P-32]ATP (K-d: 14 +/- 9 nM; B-max: 1.7 +/- 1.1 pmol/mg protein; mean +/- S.D.). Competition experiments showed that only one third of these sites bound 2-methylthio-ATP (2-MeSATP) with high affinity (K-i: 21 +/- 5 and 14 +/- 10 nM, mean +/- S.D., for [S-35]ATP gamma S and [alpha-P-32]ATP, respectively) and might therefore represent the P-2Y receptors. UTP did not compete with [S-35]ATP gamma S or [alpha-P-32]ATP for binding at the remaining sites, indicating that they are not the P-2U receptors. No high-affinity UTP binding sites could be detected using [alpha-P-32]UTP. [S-35]ATP gamma S binding to intact bovine aortic endothelial cells was competed by ATP gamma S (K-d: 1.0 +/- 0.5 mu M; mean +/- S.D.), but not by 2-MeSATP and UTP, indicating that these binding sites are neither the P-2Y nor the P-2U receptors.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 36 条
[1]  
ALLSUP DJ, 1990, MOL PHARMACOL, V38, P84
[2]   P2 PURINOCEPTORS ON VASCULAR ENDOTHELIAL-CELLS - PHYSIOLOGICAL SIGNIFICANCE AND TRANSDUCTION MECHANISMS [J].
BOEYNAEMS, JM ;
PEARSON, JD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (01) :34-37
[3]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[4]   REGULATION OF P-2Y-PURINOCEPTOR-MEDIATED PROSTACYCLIN RELEASE FROM HUMAN-ENDOTHELIAL CELLS BY CYTOPLASMIC CALCIUM-CONCENTRATION [J].
CARTER, TD ;
HALLAM, TJ ;
CUSACK, NJ ;
PEARSON, JD .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1181-1190
[5]   ADENINE-NUCLEOTIDE ANALOGS, INCLUDING GAMMA-PHOSPHATE-SUBSTITUTED ANALOGS, ARE METABOLIZED EXTRACELLULARLY IN INNERVATED FROG SARTORIUS MUSCLE [J].
CASCALHEIRA, JF ;
SEBASTIAO, AM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (01) :49-59
[6]  
COOPER CL, 1989, J BIOL CHEM, V264, P6202
[7]  
COTE S, 1993, AM J PHYSIOL, V264, pH1498, DOI 10.1152/ajpheart.1993.264.5.H1498
[8]  
FILTZ TM, 1994, MOL PHARMACOL, V46, P8
[9]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[10]  
FRELIN C, 1993, J BIOL CHEM, V268, P8787